Aligos Therapeutics, Inc.ALGSNASDAQ
Loading
Cash generated from core business operations
Latest
$-82.50M
↓ 17% vs avg
Percentile
P14
Within normal range
Streak
2 yr
Consecutive declineContracting
Average
$-70.55M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-82.50M | -2.2% |
| 2024 | $-80.74M | -2.2% |
| 2023 | $-79.00M | +0.5% |
| 2022 | $-79.39M | +31.4% |
| 2021 | $-115.66M | -55.7% |
| 2020 | $-74.26M | -58.8% |
| 2019 | $-46.77M | -673.1% |
| 2018 | $-6.05M | - |